Stock A043100 SOLCO BIOMEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Solco Biomedical Co., Ltd.

Equities

A043100

KR7043100007

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
426 KRW -1.39% Intraday chart for Solco Biomedical Co., Ltd. +0.71% +2.40%
14/03 Solco Biomedical Co., Ltd. announced that it expects to receive KRW 13 billion in funding from MDS Intelligence Inc. CI
2023 Solco Biomedical Co., Ltd. announced that it has received KRW 900 million in funding CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 59,353 31,051 22,637 63,177 30,779 27,609
Enterprise Value (EV) 1 59,018 41,713 37,500 76,028 43,621 46,763
P/E ratio -3.28 x -1.65 x 13.7 x -15.3 x -3.96 x -1.38 x
Yield - - - - - -
Capitalization / Revenue 2.63 x 1.45 x 0.99 x 2.64 x 1.32 x 1.03 x
EV / Revenue 2.62 x 1.95 x 1.64 x 3.17 x 1.86 x 1.74 x
EV / EBITDA -4.38 x -4.47 x 9.44 x -16.7 x -9.15 x -3.48 x
EV / FCF -6.18 x -6.16 x -8.11 x -16.6 x -10.2 x -13.1 x
FCF Yield -16.2% -16.2% -12.3% -6.02% -9.83% -7.63%
Price to Book 1.15 x 0.95 x 0.66 x 1.96 x 1.06 x 1.45 x
Nbr of stocks (in thousands) 57,759 57,759 57,747 60,747 65,767 66,367
Reference price 2 1,028 537.6 392.0 1,040 468.0 416.0
Announcement Date 19/03/19 20/03/20 19/03/21 18/03/22 21/03/23 21/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 22,541 21,442 22,854 23,951 23,396 26,878
EBITDA 1 -13,478 -9,335 3,972 -4,557 -4,766 -13,436
EBIT 1 -15,431 -11,131 2,879 -5,780 -6,046 -14,707
Operating Margin -68.46% -51.91% 12.6% -24.13% -25.84% -54.72%
Earnings before Tax (EBT) 1 -15,360 -18,786 1,637 -4,179 -7,765 -21,398
Net income 1 -15,350 -18,764 1,647 -4,075 -7,383 -19,966
Net margin -68.1% -87.51% 7.21% -17.01% -31.56% -74.28%
EPS 2 -313.0 -324.9 28.51 -68.17 -118.1 -301.0
Free Cash Flow 1 -9,544 -6,767 -4,626 -4,580 -4,287 -3,568
FCF margin -42.34% -31.56% -20.24% -19.12% -18.32% -13.28%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19/03/19 20/03/20 19/03/21 18/03/22 21/03/23 21/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 10,662 14,863 12,852 12,842 19,154
Net Cash position 1 334 - - - - -
Leverage (Debt/EBITDA) - -1.142 x 3.742 x -2.82 x -2.694 x -1.426 x
Free Cash Flow 1 -9,544 -6,767 -4,626 -4,580 -4,287 -3,568
ROE (net income / shareholders' equity) -31.1% -44.2% 4.82% -12.4% -25% -83.9%
ROA (Net income/ Total Assets) -13.8% -10.6% 3.17% -6.35% -6.84% -17.2%
Assets 1 1,11,286 1,77,411 51,997 64,175 1,07,957 1,16,334
Book Value Per Share 2 890.0 566.0 594.0 531.0 441.0 287.0
Cash Flow per Share 2 155.0 49.40 42.70 84.90 56.10 35.40
Capex 1 6,790 1,584 1,448 867 916 1,458
Capex / Sales 30.12% 7.39% 6.33% 3.62% 3.92% 5.42%
Announcement Date 19/03/19 20/03/20 19/03/21 18/03/22 21/03/23 21/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Devices & Implants

1st Jan change Capi.
SOLCO BIOMEDICAL CO., LTD. Stock Solco Biomedical Co., Ltd.
+2.40% 20.97M
STRYKER CORPORATION Stock Stryker Corporation
+12.07% 128B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.04% 10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+0.91% 8.82B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+16.72% 7.19B
GLAUKOS CORPORATION Stock Glaukos Corporation
+25.15% 4.99B
AXONICS, INC. Stock Axonics, Inc.
+7.17% 3.4B
ENOVIS CORPORATION Stock Enovis Corporation
-1.36% 3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-8.73% 2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-10.15% 2B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. A043100 Stock
  4. Financials Solco Biomedical Co., Ltd.